CorMedix (CRMD) Interest & Investment Income (2010 - 2025)
CorMedix's (CRMD) quarterly Interest & Investment Income came in at $889981.0 in Q4 2025, up 74.3% year-on-year from $510593.0 in Q4 2024, and down 42.96% quarter-over-quarter from $1.6 million in Q3 2025.
CorMedix (CRMD) Interest & Investment Income (2010 - 2025) Analysis & Trends
CorMedix has disclosed Interest & Investment Income across 15 years of filings, most recently posting $889981.0 for Q4 2025.
- Interest & Investment Income for Q4 2025 came in at $889981.0, up 74.3% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.8 million (up 49.13% YoY), and the FY2025 annual result was $3.8 million, up 49.13% from the prior year.
- Interest & Investment Income came in at $889981.0 for Q4 2025 at CorMedix, down from $1.6 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.6 million in Q3 2025 to a low of $3022.0 in Q3 2021.
- The 5-year median for Interest & Investment Income is $530388.0 (2023), against an average of $472363.5.
- Across the five-year window, Interest & Investment Income sank 94.23% in 2021 and soared 4102.08% in 2022, its largest moves.
- CorMedix's Interest & Investment Income stood at $4367.0 in 2021, then jumped by 4102.08% to $183505.0 in 2022, then soared by 401.37% to $920043.0 in 2023, then tumbled by 44.5% to $510593.0 in 2024, then jumped by 74.3% to $889981.0 in 2025.
- The last three Interest & Investment Income figures came in at $889981.0 (Q4 2025), $1.6 million (Q3 2025), and $828949.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn | 889,981.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 889,981.00 |
| Sep 30, 2025 | 1.56 Mn |
| Jun 30, 2025 | 828,949.00 |
| Mar 31, 2025 | 566,797.00 |
| Dec 31, 2024 | 510,593.00 |
| Sep 30, 2024 | 553,856.00 |
| Jun 30, 2024 | 657,366.00 |
| Mar 31, 2024 | 857,186.00 |
| Dec 31, 2023 | 920,043.00 |
| Sep 30, 2023 | 765,241.00 |
| Jun 30, 2023 | 550,183.00 |
| Mar 31, 2023 | 446,384.00 |
| Dec 31, 2022 | 183,505.00 |
| Sep 30, 2022 | 93,417.00 |
| Jun 30, 2022 | 35,342.00 |
| Mar 31, 2022 | 13,751.00 |
| Dec 31, 2021 | 4,367.00 |
| Sep 30, 2021 | 3,022.00 |
| Jun 30, 2021 | 3,340.00 |
| Mar 31, 2021 | 3,675.00 |